Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/21/2025
CureGene Completes Series B+ Financing to Advance Cardiometabolic and ...
5/21/2025
CRISPR and Sirius Forge Strategic Alliance for Next-Gen siRNA Therapy
5/21/2025
China Approves InnoCare's Tafasitamab for R/R DLBCL
5/21/2025
China Surges Ahead in Oncology Licensing, GlobalData Reports
5/21/2025
China's Drugstores Decline Amid Boom in Online Healthcare
5/21/2025
Accropeutics Reports Phase 2 Psoriasis Success with TYK2/JAK1 Inhibito...
5/20/2025
Pfizer Enters into $6B Exclusive Licensing Agreement with 3SBio
5/20/2025
Evive Bio Partners with LENIS Farma to Expand Ryzneuta® Distribution ...
5/20/2025
Nuance Reports Positive Top-Line Results from Phase 3 Trial of Ensifen...
5/20/2025
JHM Secures Strategic Investment to Advance Synthetic Biology Innovati...
5/20/2025
WuXi Bio Transfers Leverkusen Facility to Terumo in €150 Million Deal
5/20/2025
BeiGene Advances BTK Degrader BGB-16673 in Head-to-Head Phase 3 Trial
5/20/2025
SparX and Mitsubishi Tanabe Forge Strategic ADC Research Collaboration
5/20/2025
ArkBio Announces Positive Phase II Results of AK3280
5/20/2025
3SBio Advances SSGJ-707 into Phase 3 Trial for NSCLC
5/20/2025
CTTQ Initiates Phase 3 Trial of HER2-Targeting Bispecific ADC TQB2102
5/20/2025
Innovent's XNW5004 Receives Breakthrough Therapy Designation
5/20/2025
CDE Solicits Comments on the 94th Batch of Reference Formulations for ...
5/20/2025
CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...
5/20/2025
CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...
5/20/2025
CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...
5/20/2025
CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...
5/20/2025
How Trump's Proposed Price Cuts Could Hurt China's Innovative Drugmake...
5/20/2025
'China's Ozempic' may vie with Eli Lilly, Novo Nordisk for global weig...
5/16/2025
SMEI: China's Pharmaceutical Industry Seeks Stability and Innovation A...
5/16/2025
US Tariffs on Pharmaceuticals Could Hit Chinese Export Firms’ Profit ...
5/16/2025
ArkBio Reports Positive Mid-Stage Results for Anti-Fibrotic Candidate ...
5/16/2025
China Approves Haisco Pharma's Anrikefon (HSK21542) for Postoperative ...
5/16/2025
CSPC and Cipla Forge Exclusive U.S. Licensing Deal for Irinotecan Lipo...
5/16/2025
China Approves Xuanzhu Bio's Birociclib for HR+/HER2- Advanced Breast ...
Page:
1
/
767
Total number of articles:
22984
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit